Treatments for Breast Cancer

Below is a listing of treatments, therapies, and surgeries for breast cancer. Click on one to read more information or connect with others currently using it.

View:

Ado-Trastuzumab

Overview
Ado-Trastuzumab Emtansine is a prescription drug approved by the Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-Trastuzumab Emtansine may be pre... read more

Afinitor (Everolimus)

Overview
Afinitor is a prescription drug approved by the Food and Drug Administration (FDA) to treat advanced breast cancer in combination with Exemestane... read more

Arimidex (Anastrozole)

Overview
Arimidex is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 to treat estrogen receptor-positive breast cancer in postmenopausal women. Arimidex is also known by its drug... read more

Aromasin (Exemestane)

Overview
Aromasin is a prescription drug approved by the Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer in postmenopausal women. Aromasin is also known by its drug... read more

Axillary lymph node dissection

Overview
Axillary lymph node dissection is the surgical removal of several lymph nodes, usually between five and 30, from the underarm area. It is both a diagnostic procedure performed in order to determine wh... read more

Bilateral Mastectomy

Overview
Mastectomy is surgery intended to remove all breast tissue. Mastectomy to remove one breast is referred to as unilateral mastectomy; if bot... read more

Chemotherapy

Overview
Chemotherapy is the treatment of cancer with drugs. Chemotherapy drugs may be taken intravenously or orally. Chemotherapy may be given after surgery (referred to as adjuvant chemotherapy), before surg... read more

Clinical Trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for breast cancer. Clinical trials are the only way that new treatments for breast cancer ca... read more

Cold Cap

Overview

Cold caps cool the scalp to help minimize or prevent hair loss caused by chemotherapy.

What does it involve?
Scalp cooling works by reducing blood flow to the scalp before, during, and a... read more

Evista (Raloxifene)

Overview
Evista is a prescription drug approved by the Food and Drug Administration (FDA) in 2007 to help prevent the development of invasive breast cancer in postmenopausal women who are at high risk for the ... read more

Fareston (Toremifene)

Overview
Fareston is a prescription drug approved by the Food and Drug Administration (FDA) in 1997 to delay the progression of metastatic, estrogen receptor-positive breast cancer in postmenopausal women. Far... read more

Faslodex (Fulvestrant)

Overview
Faslodex is a prescription drug approved by the Food and Drug Administration (FDA) in 2002 to treat estrogen receptor-positive breast cancer in postmenopausal women whose cancer progressed after treat... read more

Femara (Letrozole)

Overview
Femara is a prescription drug approved by the Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is also known by its drug nam... read more

Herceptin (Trastuzumab)

Overview
Herceptin is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy re... read more

Ibrance (Palbociclib)

Overview

Ibrance is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in combination with Femara. Ibrance is prescribed in cases where women are postmen... read more

Kadcyla (Ado-Trastuzumab Emtansine)

Overview
Kadcyla is a prescription drug approved by the Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Kadcyla may be prescribed in cases where Trastuzumab a... read more

Kisqali (Ribociclib)

Overview
Kisqali is a prescription drug approved by the Food and Drug Administration (FDA) as an initial endocrine-based treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (H... read more

Lumpectomy

Overview
Lumpectomy, also known as breast-conserving or breast-sparing surgery, wide local excision, or partial mastectomy, is surgery to remove a breast cancer tumor along with some of the normal breast tissu... read more

Lynparza (Olaparib)

Overview
Lynparza is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer. Lynparza may be prescribed in either hormone receptor-positive or -negative cases,... read more

Mastectomy

Overview
Mastectomy is surgery intended to remove all breast tissue. It is used as treatment for breast cancer or as prevention for women who are at especially high risk for developing breast cancer. Mastectom... read more

Nerlynx (Neratinib)

Overview
Nerlynx is a prescription drug approved by the Food and Drug Administration (FDA) as adjuvant (post-surgery) treatment for adults with early-stage breast cancer in which HER2 is overexpressed or ampli... read more

Neulasta (Pegfilgrastim)

Overview

Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is als... read more

Neupogen (Filgrastim)

Overview
Neupogen is a prescription drug approved by the Food and Drug Administration (FDA) to help prevent febrile neutropenia (a lack of white blood cells, plus fever). If your white blood cell count is low ... read more

Ogivri (Trastuzumab-dkst)

Overview
Ogivri is a prescription drug approved by the Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name, Trast... read more

Perjeta (Pertuzumab)

Overview
Perjeta is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 the... read more

Pertuzumab

Overview
Pertuzumab is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 ... read more

Radiation Therapy

Overview
Radiation therapy helps prevent the return or spread of cancer. It is most frequently used after surgery, especially lumpectomy. If you hav... read more

Reconstructive Surgery

Overview
Many women choose reconstructive surgery after a mastectomy or bilateral... read more

Sentinel node biopsy

Overview
Sentinel node biopsy is the surgical removal of one or more lymph nodes for testing. It is a diagnostic procedure performed in order to determine whether breast cancer has developed the ability to spr... read more

Tamoxifen

Overview
Tamoxifen is a prescription drug first approved by the Food and Drug Administration (FDA) in 1977 to treat breast cancer. Tamoxifen was later also approved to prevent breast cancer. Tamoxifen is commo... read more

Trastuzumab

Overview
Trastuzumab is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy ... read more

Tykerb (Lapatinib)

Overview
Tykerb is a prescription drug approved by the Food and Drug Administration (FDA) in 2007 to treat metastatic breast cancer in combination with Capecitabine in cases where tumors overexpress the HER2 p... read more

Verzenio (Abemaciclib)

Overview
Verzenio is a prescription drug approved by the Food and Drug Administration (FDA) to treat advanced or metastatic breast cancer. Verzenio may be prescribed in combination with Faslodex (Fulvestrant),... read more

Xeloda (Capecitabine)

Overview
Xeloda is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to pa... read more

Zarxio (Filgrastim-sndz)

Overview
Zarxio is a prescription drug approved by the Food and Drug Administration (FDA) to treat febrile neutropenia (a lack of white blood cells, plus fever). If you have neutropenia caused by chemotherapy ... read more

Continue with Facebook
Sign up with your email
Already a Member? Log in

Welcome back!

Log in to gain access to the thousands of comments being shared on MyBCTeam.

log in
×